Category Archives: Food & Drug Recalls

FDA Commissioner Margaret A. Hamburg’s Statement on the 50th Anniversary Surgeon General’s Report on Smoking and Health

The 50th anniversary of the release of the Surgeon General’s Report on Smoking and Health is an opportunity to reflect on the important progress that has been made in tobacco control and to look ahead on addressing this critical public health issue. In 2014, tobacco remains the leading preventable cause of disease and death in this country. For five decades, the Department of Human Health and Services has played a critical role in developing and implementing proven comprehensive tobacco control programs and policies aimed at preventing tobacco use, especially among youth, and encouraging cessation. The Surgeon General’s Report provides a scientific foundation for public health action to reduce the public health impact of tobacco use.

FDA allows marketing for first of-its-kind post-natal test to help diagnose developmental delays and intellectual disabilities in children

Today the U.S. Food and Drug Administration authorized for marketing the Affymetrix CytoScan Dx Assay, which can detect chromosomal variations that may be responsible for a child’s developmental delay or intellectual disability. Based on a blood sample, the test can analyze the entire genome at one time and detect large and small chromosomal changes.

Midwest Wholesale Issues Voluntary Recall of Boost Ultra, XZone Gold, Sexy Monkey, Triple MiracleZen Platinum, Magic for Men, "New" Extenze, and New XZen Platinum Marketed as a Dietary Supplements Due to the Presence of Undeclared Drug Ingredients

Nixa, MO, Midwest Wholesale is voluntarily recalling the following products and Lot numbers. This recall is being conducted to the consumer level. FDA analysis found these products to contain undeclared Sildenafil and/or Tadalafil, the active ingredients in FDA-approved prescription drugs used to treat erectile dysfunction (ED).